Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
46.9M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
51.7M
-
Shares change
-
+3.37M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$70.7M
-
Put/Call ratio
-
0.15
-
Number of buys
-
97
-
Number of sells
-
-85
-
Price
-
$20.29
Significant Holders of Core Laboratories Inc. /DE/ - Common Shares (CLB) as of Q2 2024
224 filings reported holding CLB - Core Laboratories Inc. /DE/ - Common Shares as of Q2 2024.
Core Laboratories Inc. /DE/ - Common Shares (CLB) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.7M shares
.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (10.3M shares), BlackRock Inc. (7.8M shares), VANGUARD GROUP INC (5.53M shares), DISCIPLINED GROWTH INVESTORS INC /MN (4.46M shares), EARNEST PARTNERS LLC (3.29M shares), STATE STREET CORP (1.92M shares), CONGRESS ASSET MANAGEMENT CO /MA (1.69M shares), MORGAN STANLEY (1.08M shares), GEODE CAPITAL MANAGEMENT, LLC (1.05M shares), and ROYCE & ASSOCIATES LP (937K shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.